chrisvoncsefalvay/vaers-outcomes huggingface dataset:
after getting second COVID vaccine had an early period followed by a late period followed by a missed period followed by an extremely heavy 11-day long period followed by another late heavy period; after getting second COVID vaccine had an early period followed by a late period followed by a missed period followed by an extremely heavy 11-day long period followed by another late heavy period; after getting second COVID vaccine had an early period followed by a late period followed by a missed period followed by an extremely heavy 11-day long period followed by another late heavy period; after getting second COVID vaccine had an early period followed by a late period followed by a missed period followed by an extremely heavy 11-day long period followed by another late heavy period; after getting second COVID vaccine had an early period followed by a late period followed by a missed period followed by an extremely heavy 11-day long period followed by another late heavy period; after getting second COVID vaccine had an early period followed by a late period followed by a missed period followed by an extremely heavy 11-day long period followed by another late heavy period; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 13Feb2021 09:00 (Lot number: EM9810) at the age of 46 years as dose 2 , single for covid-19 immunisation. Relevant medical history included: "Fibromyalgia" (unspecified if ongoing). Concomitant medication(s) included: LAMOTRIGINE; LDNIL. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot number: EL3246, administration time: 08:30 AM, vaccine location: Left arm), administration date: 20Jan2021, for Covid-19 Immunization. The following information was reported: MENSTRUATION IRREGULAR (non-serious), POLYMENORRHOEA (non-serious), MENSTRUATION DELAYED (non-serious), AMENORRHOEA (non-serious), HEAVY MENSTRUAL BLEEDING (non-serious), OLIGOMENORRHOEA (non-serious) all with onset 06Mar2021 08:00, outcome "not recovered" and all described as "after getting second COVID vaccine had an early period followed by a late period followed by a missed period followed by an extremely heavy 11-day long period followed by another late heavy period". Therapeutic measures were not taken as a result of menstruation irregular, polymenorrhoea, menstruation delayed, amenorrhoea, heavy menstrual bleeding, oligomenorrhoea.  Additional information: Patient's periods were always regular, light, short, and on time before the second COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
I have severe neuropathy, never damage, in my R leg which I control with Hydrocodone.  It has been under control.  Within hours that leg was very painful.  Nothing would alleviate it.  It was like it was before I found out what it was.  Very painful.  It has been 5 days and I am still limping and in pain.  The worst day was the day of  vax.  That night was horrible.  The next day was basically in bed with the pain and flu like symptoms.  Flu feelings are gone but this leg pain has not left.    I will not be very happy at all if it does not lesson to at least what it was pre-vax.    I have a friend who experienced the same with a problem she has with nerves.  Said it lasted a week.
Initial nurse report received on 20 Jul 2010: The patient received MENVEO (box lot. No. 100022), 0.5 ml, intramuscularly, on an unspecified date. The patient received 0.5 ml IM dose MenCYW instead of being reconstituted with MenA on an unspecified date. The outcome of event was not reported.
Within a minute of receiving the vaccine patient became lightheaded, dizzy and discomfort across her breast radiating to her abdomen.  Patient got juice and rested and felt better and was sent home
Severe vertigo began at 3:00 PM on 12/31/2020. Vomiting lasting approx. 9 hours (8 episodes). Unable to open eyes due to vertigo, vasovagal upon standing lasting until approx. 3:00 pm 1/2/2021. Diarrhea began approx. 8:00 pm 1/1/2021 with episodes each time after trying to eat 4 episodes. Headache lasted 3 days. Today on 1/3/2021 I have been able to keep down soup. Eyes feel tired, minimal vertigo upon moving head. No further diarrhea, vomiting.
This spontaneous report was received from a nurse practitioner refers to a patient of unknown age and gender. On 05-MAR-2013, the patient was vaccinated with the first dose of improperly stored (Oka/Merck) VARIVAX, lot#:0610AE, dose route and frequency unknown. On 08-APR-2013, the patient was vaccinated with the second dose of improperly stored (Oka/Merck) VARIVAX dose 2, lot#:0610AE. No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
Fell; couldn't get up; messed him up; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): LRN4172103.  A 55 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 55 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "high cholesterol" (unspecified if ongoing); "falls" (unspecified if ongoing); "feels like pins pricking" (unspecified if ongoing); "memory issues" (unspecified if ongoing). Concomitant medication(s) included: OCREVUS; MODAFINIL; METFORMIN; GABAPENTIN; AMINOPYRIDINE; LOSARTAN; ATORVASTATIN CALCIUM; OXCARBAZEPINE; VITAMIN D NOS. The following information was reported: FALL (non-serious) with onset 15Apr2021, outcome "unknown", described as "Fell"; DYSSTASIA (non-serious) with onset 15Apr2021, outcome "unknown", described as "couldn't get up"; FEELING ABNORMAL (non-serious) with onset 15Apr2021, outcome "unknown", described as "messed him up".  Additional information: Case Details: Patient's past medical history included: high cholesterol, falls. Patient's concurrent condition included: feels like pins pricking, memory issues. Patient's concomitant medication included: Ocrevus, Modafinil, Metformin, Gabapentin, Aminopyridine, Losartan, Atorvastatin, Oxcarbazepine, Vitamin D. On unknown date, patient started therapy with Pfizer Covid 19 Vaccine for unknown indication. On 15Apr2021, it was reported that patient experienced: Fell, messed him up, couldn't get up. The outcome of the reported event(s) was Unknown. No further information was reported. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Right wrist started pain on D12-30-20 8 pm. and this am its swollen and painful . Pain is 8/10 and cannot hold any thing. After breakfast I took Tylenol 500 mg. one pill. When I apply warm compression feels good. I am planning to take Advil Liquid Gel200mg after lunch.
Migraine; Nausea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine), NAUSEA (Nausea) and VOMITING (Vomiting) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     Concurrent medical conditions included Migraine and Chronic pain (chronic pain from auto accident).    On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-May-2021, the patient experienced MIGRAINE (Migraine), NAUSEA (Nausea) and VOMITING (Vomiting). On 04-May-2021, MIGRAINE (Migraine), NAUSEA (Nausea) and VOMITING (Vomiting) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Urine analysis: positive for fentanyl (Positive) Positive for Fentanyl.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Extreme inflammatory response resulting in hyperglycemia and hemolytic anemia requiring  blood transfusion x 2. Pt's symptoms included dizzy, lightheaded, blurred vision, fatigue. See attached hospital and office records.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 13Apr2022 as dose 4 (booster), single (Lot number: FJ4989) at the age of 69 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "seasonal allergies" (unspecified if ongoing); "Allergy to sulfa drugs" (unspecified if ongoing), notes: Known allergies: sulfa drugs; "known allergies: mussels" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Codeine, reaction(s): "Allergy"; Cefazolin sodium, reaction(s): "Allergy"; Bee venom, reaction(s): "Allergy". The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "recovering" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical information: The patient received vaccine. The patient had not received other medication in two weeks:
PT HAD HISTORY OF "PASSING OUT/SYNCOPE" WHEN RECEIVING IMMUNIZATIONS AND BLOOD WORK. AFTER THE COVID IMZ, PT SAT DOWN NEXT TO HER HUSBAND AND SOON BECAME LIMP AND FELL DOWN TO THE FLOOR. PT WAS ALTERED FOR ABOUT 15 MINUTES, AND HER BLOOD PRESSURE/BLOOD GLUCOSE WAS WNL.  911 WAS CALLED, AND PT WAS TAKEN ON STRETCHER TO BE ASSESSED @ AMBULANCE. PT WAS COHERENT AT THAT TIME, AND SAID SHE DID NOT WANT TO GO TO THE HOSPITAL.
Patient got his booster on the 13th, per wife, patient was fatigued and coughing the day after the shot, on the 15th went into cardiac arrest
On 1/18/21, ten days after receiving the first dose of the Moderna vaccine I noted redness and swelling around the injection site. This worsened over the next 24 hours and became increasingly itchy.
Headache, sweating profusely and nauseous  normal sinus rhythum/clear lungs/BS 89/BP 110/60
On 11/19/2020 I administered an MMRV vaccine to the above client. The client should have been given a seperate MMR and varicella vaccine due to her age. The client was notified of the Error on 11/23/2020 by this nurse. The client denies any adverse symptoms and denies any treatment.
On Monday January 18th, I woke up grapping for air, unable to breathe.  Was taken to the ER at hospital and admitted with blood clots in my lungs.
This patient was given afluria which is only to be given to 18 and older. no reaction to vaccine.  I-92579218 and I-92318744
Sinus pressure, nasal congestion, frontal headache, dizziness-- initially. Then after 3 days, visual halo/flashes, muscle twitching and numbness/tingling in hands. Muscle twitching stopped 2/24/10 but numbness continues. Still w/ visual symptoms. Has seen a neurologist and an ophthalmologist. No diagnoses made/ no distinct pathology found by them.
Swelling and pain in several joints, including middle finger right hand, metatarsals of left foot, and left knee
Information has been received from a pharmacist concerning 2 pts who were vaccinated with pneumococcal vaccine 23 polyvalent. Subseqently, the pts experienced injection site redness, "localized reactions". Medical attention was sought. No further information is available.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). A 62-year-old male patient received BNT162b2 (BNT162B2), in Nov2021 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunization; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Infection with COVID-19". Symptoms: sore throat, hoarse voice, cough, fatigue, nasal congestion, runny nose and headache. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: infection with COVID-19. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected. Sender's Comments: The causal association cannot be excluded between the reported events and suspect vaccine use based on known drug safety profile.
Approx. 10 minutes after vaccine administration, patient reported feelings of lightheaded ness. Upon assessment, vitals were normal. Patient was advised to follow with up PCP
She had chills starting when she woke up the day after the shot. By about 7pm, she had spiked a fever of 102.5. She was burning hot all over and continued with chills. She was crying and scared. She said her body ached. Her arms hurt where the injection sites were but there was no bump or rash that i could see. We gave her TYLENOL at 9 and her fever of 102.5 continued until about midnight. (She rarely ever gets a high fever like this). She was up throughout the night. By morning her fever was ranged from 100-101 and stayed that way until about 3pm when it dropped to 99.5. Then it continued to drop and she was fine by 9 pm. She was seen by her dr. this afternoon and missed school (two days after the shot) where they tested her blood and did a flu shot. She was negative. She had no other symptoms.
first dose of Shingrix in 2018 and had not received dose two.; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in 2018.).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows:  The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter consent to follow up.
Per patient sha had fever 100.6 F. swelling and flushing (face). body aches
Got very hot and clammy but at the same time had the goosebumps; Got very hot and clammy but at the same time had the goosebumps; Got very hot and clammy but at the same time had the goosebumps; My whole body was as if I was sun burnt; My heart started to race; This is a spontaneous report from a contactable consumer (patient).  A 45-year-old female patient received BNT162B2, (Pfizer COVID Vaccine, lot number: EK9231, expiry date: Apr2021) intramuscular on an unspecified date at single dose on right arm for COVID-19 immunisation.  Medical history included migraine from an unknown date and unknown if ongoing.  Concomitant medication included nortriptyline for migraine, botulinum toxin type a (BOTOX) for migraine and birth control medication.  The patient stated that, "I was wondering if this was a reaction to the vaccination I had today. So I ended up 3 hours after I received the vaccine, I got very hot and clammy but at the same time had the goosebumps and then my whole body was as if I was sun burnt and my heart started to race. And then my whole body was red as if I had a sunburn. Actually I went to the ER today and they just did lab work because of the way I was feeling. All they gave me in the emergency room is IV fluids."  Therapeutic measures taken as a result of the events included IV fluids. The outcome of the events was unknown.
Dose_number=3 date=29Sep2021; COVID 19 Treatment; Dose_number=3 date=29Sep2021; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52-year-old male patient received BNT162b2 (BNT162B2), on 29Sep2021 at 13:00 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Past drug history included: Nsaids, reaction(s): "Allergy_NSAIDS". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "not recovered" and all described as "Dose_number=3 date=29Sep2021; COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (06May2022) Negative; (08May2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Body stiffness, eyes rolled back, face turned red, went limp. No longer than 10 seconds.
COVID-19 symptoms started on evening of June 17 and day of June 18. I tested positive on June 19. I had a fever on the 19th and 20th. Symptoms included cold-like symptoms, fever, minor headache, and cough. My fever was measured at 101.4, possibly could have hit 102. Symptoms broke by the 21st. I was on Paxlovid and things got better pretty quickly. No lingering symptoms.
Six days post first injection I developed Moderna Arm. The left arm around the injection site developed a grapefruit size, extremely red, swollen, hard, hot, and itchy welt.
Patient woke up Sunday morning to find a bruised area on her right arm, slightly below site of injection. At time of presentation to pharmacy, area was ~4in long by ~3" wide. Color varied with top being more green/yellow and bottom of bruise purple/blue. Patient denied any pain or tender at site of bruise, but reported slight pain at time of injection.
No adverse events reported by patient.  Vaccine was given three days past the beyond use date of 30 days from when the vial had been thawed and placed in refrigerator.  Beyond use date was 10/11/21. Vaccine dispensed 10/14/21.
7/7/07 - shooting pain in neck, mid back and arms.  Electrical sensation all over his body.  7/7/07 - unable to move fingers or arms, weakness in legs.  Numbness on chest, upper and lower body, constipation.  7/28/07 - he needed help being fed and go to the bathroom.  1/22/08 - bone fusion surgery on his neck.  6/06/2008 MR received for ER visit 7/20/2007 with DX:  Back pain with paresthesias to hands and arms.  Degenerative Disc Disease.  Pt presented to ER with c/o numbness/tingling of the L arm/hand and legs and thoracic and lumbar back pain which was non-traumatic in origin. Pt also reports recent onset of unsteady gait and feeling uncoordinated. PE WNL with strength noted as 4-5. D/C home.MR also received for DOS 7/25-31/2007 with D/C Dx: Multiple Sclerosis with some degenerative disc disease, potentially exacerbating his cervical spine lesion. Pt retuned to ER on 7/25/07 with increased difficulty walking and standing and fine motor control.  Has required help to eat due to unsteadiness of the hands. PE (+) for poor grip strength R>L.  Downward plantar reflexes and DTRs 1+.  Neuro consult with Impression: Demyelinating. D/C to be f/u as outpt. Follow-up: Chronic fatigue, muscle and joint pain, numbness and tingling from chest down to groin area, left hip left leg to tip of the toes, can't ejaculate, problems with bladder control. Depression and Anxiety.
Fever to 102, nausea, vomiting and malaise beginning within 12 hours of vaccine. One episode of vomiting only thus far. Fever currently is 101 (24 hours later).
Coughing, fever, body aches, breathing issues, sores on roof of mouth, still sick today one week later 4/5/2021
Patient 43 YO Asian male reported adverse reaction with the first dose of COVID Vaccine. He stated that he had heart palpitation for days, then specified x 2 days after the first COVID vaccine. He reported that, he was seen by his provider for the palpitation incident. Denied  palpitation at this time at time for presenting for 2nd dose. He also was subsequently Dx with new onset hypertension as well.
Erythema, redness at site of injection extending 6" x 3" of right upper arm 24 hours after vaccine administration.
Mild cough, runny nose, loss of taste and smell, Headache, sore throat, nausea beginning on 4/20/21
Abnormally heavy menstrual flow; A spontaneous report was received from a consumer, concerning a female Hispanic patient of unspecified age, who received Moderna's COVID-19 vaccine and experienced abnormally heavy menstrual flow.   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On 23-Dec-2020, prior to the onset of event, the patient received their first of two planned doses of mRNA-1273 (lot # unknown) intramuscularly for prophylaxis of COVID-19 infection.   The consumer reported that her colleague had experienced an abnormally heavy menstrual flow after receiving the vaccine. Reporter also stated that she wonders if the vaccine affects certain demographics differently. Treatment information was not provided.   Action taken with mRNA-1273 in response to the event was not provided.   The event, abnormally heavy menstrual flow was considered unknown.; Reporter's Comments: This case concerns a Hispanic, female patient, who experienced a non-serious unexpected event of Menorrhagia. The event occurred 2 days after first dose of mRNA-1273, lot # unknown. Treatment details was no provided. Very limited information regarding these events has been provided at this time. Based on the current available information and temporal association between the use of the product and onset of the event a causal relationship cannot be excluded. Additional information has been requested.
Presented to emergency department on 3/28/21 with difficulty breathing and found to be COVID-19 positive.  He was admitted for further management. Patient was discharged on 4/4/21.
Migraine that has lasted 4 days Blood pressure is going up and down chills nausea
received dose from vial punctured more than 12 hours ago; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received dose from vial punctured more than 12 hours ago) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.   On 28-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (received dose from vial punctured more than 12 hours ago). On 27-Oct-2021, EXPIRED PRODUCT ADMINISTERED (received dose from vial punctured more than 12 hours ago) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No Treatment medications were reported.